Evidence map›Paper›PMID 21451107›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Jennifer D Stone, David H Aggen, Adam S Chervin, Samanthi Narayanan, Thomas M Schmitt, Philip D Greenberg, David M Kranz

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phenotypic models of T cell activation.Nature reviews. Immunology · 2014
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jennifer D StoneDepartment of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA. jstone@illinois.edu
David H Aggen
Adam S Chervin
Samanthi Narayanan
Thomas M Schmitt
Philip D Greenberg
David M Kranz
University of Illinois Urbana-Champaign · USUniversity of Washington · US

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
Protein Expression and Peptide CoreP01CA097296 · NCI · UNIVERSITY OF CHICAGO · PI SCHREIBER, HANS · 2003 to 2012
$15.0M
Mechanisms of Murine Turmor Eradication by ImmunotherapyR01CA033084 · NCI · UNIVERSITY OF WASHINGTON · PI GREENBERG, PHILIP D · 1986 to 2017
$5.8M
Structure, Function &Engineering of Tau Cell ReceptorsR01GM055767 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KRANZ, DAVID M. · 1997 to 2009
$2.4M
NCI NIH HHS CA097296NCI NIH HHS P01 CA018029NCI NIH HHS P01 CA097296NCI NIH HHS P01 CA18029NCI NIH HHS R01 CA033084NCI NIH HHS R01 CA33084NIGMS NIH HHS GM55767NIGMS NIH HHS R01 GM055767
6 · The paper itself

Abstract

Nonstimulatory or endogenous peptide-MHC (pepMHC) presented on the surfaces of APCs, either alone or alongside agonist pepMHC, plays various roles in T cell selection and activation. To examine these properties in more detail, we explored several model systems of TCR and pepMHC ligands with sufficient affinity to be activated in the absence of CD8. The TCRs had a range of affinities for agonist and nonstimulatory ligands and were restricted by MHC class I alleles with different properties. We observed CD8-independent antagonism from TCR-pepMHC interactions with very low affinities (e.g., K(D) = 300 μM). In addition, endogenous peptide-L(d) complexes on APCs antagonized activation of coreceptor (CD8)-negative 2C T cells even by the strong agonist QL9-L(d). In contrast, TCRs m33 and 3D-PYY, restricted by K(b) and D(b), respectively, did not show signs of antagonism by endogenous pepMHC in the absence of CD8. This did not appear to be an inherent difference in the ability of the TCRs to be antagonized, as altered peptide ligands could antagonize each TCR. In the presence of CD8, endogenous pepMHC ligands acted in some cases as coagonists. These results show that endogenous pepMHC molecules exhibit complex behavior in T cells, leading to either reduced activity (e.g., in cases of low coreceptor levels) or enhanced activity (e.g., in presence of coreceptor). The behavior may be influenced by the ability of different TCRs to recognize endogenous pepMHC but also perhaps by the inherent properties of the presenting MHC allele.

Indexed as

AnimalsAntigen PresentationAutoantigensCD8 AntigensCell SeparationEnzyme-Linked Immunosorbent AssayFlow CytometryHistocompatibility Antigens Class ILymphocyte ActivationMicePeptidesReceptors, Antigen, T-CellT-LymphocytesAutoantigensCD8 AntigensHistocompatibility Antigens Class IPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID21451107
PMCPMC3095212
OpenAlexW1923300575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.